Method For Diagnosing Mastitis In A Lactating Animal
20170208769 ยท 2017-07-27
Assignee
Inventors
- Fred W. Quimby (New Durham, NH, US)
- Rolf Von Rheinbaben (Tutzing, DE)
- Michael G. Tokman (Ithaca, NY, US)
Cpc classification
International classification
Abstract
The invention relates to a method for diagnosing mastitis in a lactating and preferably bovine animal, the method comprising recording data, the data having been obtained from analyzing a series of milk samples, the series of milk samples in turn having been obtained by periodically milking an animal, the data including total and/or differential leukocyte counts and changes in these count(s) between subsequent samples, wherein the differential leukocyte counts include the lymphocyte count, the macrophage count and the neutrophil count; and evaluating the recorded data to obtain information on the presence of mastitis and/or stage of mastitis and/or on the microorganism responsible for mastitis.
Claims
1. A method for diagnosing mastitis in a lactating and preferably bovine animal, the method comprising: recording data, the data having been obtained from analyzing a series of milk samples, the series of milk samples in turn having been obtained by periodically milking an animal, the data including total and/or differential leukocyte counts and changes in these count(s) between subsequent samples, wherein the differential leukocyte counts include the lymphocyte count, the macrophage count and the neutrophil count; and evaluating the recorded data to obtain information on the presence of mastitis and/or stage of mastitis and/or on the microorganism responsible for mastitis.
2. The method of claim 1, wherein evaluating the recorded data includes determining mean values and confidence intervals for the total and/or each of the differential leukocyte counts.
3. The method of claim 2, wherein evaluating the recorded data further includes evaluating whether the count(s) of a new sample remain within the respective confidence intervals and, if applicable, identifying a deviation.
4. The method of claim 3, wherein evaluating the recorded data further includes evaluating the deviation to identify acute infection, chronic infection or recovery.
5. The method of claim 4, wherein the method further includes identifying and outputting recommendations on whether to dump the milk or treat the animal on the basis of the result of the evaluation of the deviation.
6. The method of claim 2, wherein evaluating the recorded data further includes assigning the samples to threshold groups based on the mean value of the total leukocyte count.
7. The method of claim 6, wherein evaluating the recorded data further includes evaluating whether the total leukocyte count of a new sample enters a higher threshold group and, if applicable, which threshold group has been entered.
8. The method of claim 7, wherein evaluating the recorded data further includes evaluating the change of threshold groups to identify acute infection, chronic infection or recovery.
9. The method of claim 8, wherein the method further includes identifying and outputting recommendations on whether to dump the milk or treat the animal on the basis of the result of the evaluating the change of threshold groups.
10. The method of claim 6, wherein evaluating the recorded data further includes evaluating whether a threshold group has been exceeded and, if so, evaluating the recorded data to obtain information on the microorganism responsible for mastitis.
11. The method of claim 1, wherein the period for milking is once or twice daily.
12. The method of claim 1, wherein the samples constitute composite samples comprising milk from different mammary gland quarters.
13. The method of claim 1, wherein individual series of samples have been obtained for each of the four quarters of a cow.
14. A data storage medium comprising a computer-readable program configured to carry out the method of claim 1.
15. A computer configured to carry out the method of claim 1.
Description
[0033] Further details and advantages of the invention become apparent from the following example. The figures show:
[0034]
[0035]
[0036]
[0037]
[0038]
[0039]
[0040]
[0041]
[0042] As a quarter is milked in an automated milking machine, the cows ID is read using radiofrequency identification. Cows are commonly identified using a radiofrequency chip implanted subcutaneously (typically in one ear). Stored information on the cow is pulled up. Among these data are the cows DIM (days in milk number) and the previous TL, L, M and N counts. The DIM number designates the number of the actual day starting form the beginning of the lactation cycle.
[0043] As apparent from
[0044] The first analysis is recorded at DIM 3. After collecting and analyzing milk from DIM 3 to 5 the calculator determines whether or not the quarter is likely to be infected. For those quarters likely to be infected at DIM 5 the calculator initiates the subroutine 3 (SR3, see later) to follow the leukocyte patterns and terminates. The reason for this is that no normal cow after DIM 5 has a TLC in excess of 400 cells/ml without an infection, therefore this quarter will be monitored as if it were infected. Early lactation is a critical period for mastitis on a dairy due to the trauma of delivery, metabolic changes occurring at the onset of lactation and the conversion of the mammary gland from quiescent to productive. Over 30% of all new infections of the quarter take place in the first few DIM.
[0045] Any animal introduced into the herd after DIM 3 has its quarter milk information introduced directly into subroutine 1 (SR1, see later) establishing the baseline parameters for milk leukocytes. After DIM5 if the TLC is below 400,000 cells/ml the quarter is monitored to establish the baseline for the quarter (SR1).Any cow entering the milking herd which is greater than DIM5 and has a TLC<600,000 cells/ml is also monitored for baseline.
[0046]
[0047] The first sample subject to SR1 is analyzed to determine TLC. If TLC is below 600, SR1 determines the individual L, M and N counts and the relative percentages of each leukocyte type and then enters a baseline establishing step, wherein it remains active until a further milk sample is analyzed and compares TLC and the individual L, M and N counts or percentages of the further sample.
[0048] If TLC of the further sample remains below 600 if all four counts remain stable in the sense that no change of more than 50% over the first sample is observed, SR1 repeats the baseline establishing step. If the baseline establishing step can be repeated until seven subsequent sets of all four counts are obtained, SR1 establishes a baseline, i.e., the means and 95% confidence intervals for all four counts. Once the baseline is established the quarter MDLC is monitored daily until a significant deviation from baseline in the sense that either of the four counts falls outside the confidence intervals is detected. As long as no such deviation is detected, the animal is regarded healthy. If such deviation is detected, the routine initiates SR5.
[0049] Should the TLC in the first sample (or any sample before a baseline is established) lie between 600 and 1000, SR1 continues to evaluate the TLC for the next sample. Should the TLC in the next sample have increased, SR1 initiates SR3, produces an output to discard the milk and terminates. Should the TLC in the next sample have decreased, SR1 initiates SR2 and terminates.
[0050] Should the TLC in the first sample (or any sample before a baseline is established) lie above 1000, SR1 initiates SR3, produces an output to discard the milk and terminates.
[0051] Should the TLC stay below 600 but any of the four counts become unstable before a baseline is established, SR1 initiates SR1a and terminates.
[0052]
[0053]
[0054] If the TLC has increased and changed into a higher threshold group (e.g., from normal to subclinical or from subclinical to chronic 1), SR2 initiates SR3 and terminates.
[0055] If the TLC has increased but not changed into a higher threshold group, SR2 evaluates whether the N percentage has increased. If yes, SR2 initiates SR3 and terminates. If no, SR2 restarts. If the N percentage falls and either the M percentage or L percentage increases, SR2 initiates SR1 and terminates.
[0056] If the TLC has decreased, SR2 evaluates whether the N percentage has increased. If yes, SR2 initiates SR3 and terminates. If no, SR2 initiates SR1 and terminates.
[0057] Subroutines 3 and 3a (SR3 and SR3a) are initiated to follow the leukocyte profile when an infection is suspected. Whether to apply SR3 or SR3a depends on whether the TLC value of the sample under observation has increased over the previous sample and changed into a higher threshold group. If yes, SR3 is initiated. If no, SR3a is initiated.
[0058]
[0059] In a first scenario the previous threshold group was normal (TLC<150) and the new threshold group is subclinical (150-400). In this scenario SR3 determines whether the N percentage has also increased. If not, SR3 initiates SR1 and terminates. If so, SR3 remains active until a further milk sample is analyzed, i.e., enters a monitoring routine. If the TLC of the further milk sample rises above the threshold group boundary (instantly: 400) and the N percentage is above 50, SR3 produces an output to treat the animal. If not, SR3 determines whether the N percentage has increased. If not, SR3 initiates SR1 and terminates. If so, SR3 remains active and the monitoring routine is repeated or treatment may be instituted.
[0060] In a second scenario the previous threshold group was normal (TLC<150) and the new threshold group is chronic 1 (400-600). In this scenario SR3 determines whether the N percentage has increased. If so, SR3 produces an output to treat the animal. If not, SR3 enters a monitoring routine as described for the first scenario.
[0061] In a third scenario the previous threshold group was normal (TLC<150) and the new threshold group is chronic 2 or acute (>600). In this scenario SR3 initiates SR4 and produces an output to discard the milk. Additionally, SR3 enters a monitoring routine. If the TLC or N percentage of the further milk sample still rises, SR3 produces an output to treat the animal. If not, SR3 initiates SR2 and terminates.
[0062] In a fourth scenario the previous threshold group was subclinical (150-400) and the new threshold group is chronic 1 (400-600). In this scenario SR3 enters a monitoring routine. If the TLC or N percentage of the further milk sample still rises, SR3 produces an output to treat the animal. If not, SR3 initiates SR1 and terminates.
[0063] In a fifth scenario the previous threshold group was subclinical (150-400) and the new threshold group is chronic 2 (600-800). Also in this scenario SR3 enters a monitoring routine. If the TLC or N percentage of the further milk sample still rises, SR3 produces an output to discard the milk and to treat the animal. If not, SR3 initiates SR2 and terminates.
[0064] In a sixth scenario the previous threshold group was subclinical (150-400) and the new threshold group is acute (>800). In this scenario SR3 initiates SR4 and produces an output to discard the milk. Additionally, SR3 enters a monitoring routine. If the TLC or N percentage of the further milk sample still rises, SR3 produces an output to treat the animal. If not, SR3 initiates SR2 and terminates.
[0065] In a seventh scenario the previous threshold group was chronic 1 (400-600) and the new threshold group is chronic 2 (600-800). In this scenario SR3 determines whether the N percentage has increased. If not, SR3 initiates SR2 and terminates. If so, SR3 produces an output to discard the milk. Additionally, SR3 enters a monitoring routine. If the TLC of the further milk sample still rises, SR3 produces an output to treat the animal. If not, SR3 initiates SR2 and terminates.
[0066] In an eighth scenario the previous threshold group was chronic 1 (400-600) and the new threshold group is acute (>800). In this scenario SR3 initiates SR4 and produces an output to discard the milk. Additionally, SR3 enters a monitoring routine. If the TLC of the further milk sample still rises, SR3 produces an output to treat the animal. If not, SR3 initiates SR2 and terminates.
[0067]
[0068]
[0069] In the following, SR4 is explained on the basis of a 12 hour sampling frequency, assuming that the sampling frequency is increased after mastitis is detected.
[0070] This subroutine uses the previous value (12 hours ago), the value from three days ago and a value from five days ago to make a prediction, based on statistical information, whether mastitis is caused by gram positive (Gm+) or gram negative (Gm) bacteria.
[0071] The prediction schemes for two different scenarios (800TLC<1,000 and TLC1,000) are illustrated in
[0072] For example, if the instant TLC is 900, the TLC of the previous sample was 700 and the TLCs from both three and five days ago were 100, the infection is due to gram negative bacteria. This information is provided to the user.
[0073] Furthermore, based on the historic information regarding peak TLC, length of the plateau before the TLC decreases, and the change in percentages of N, M and L during the previous three samplings, a prediction of a specific bacterial species may be made.
[0074]
[0075] This subroutine differentiates between three possible scenarios.
[0076] In a first scenario, where the baseline mean TLC was 150 or smaller (normal), SR5 first determines whether the TLC has risen beyond, remained within or fallen below the confidence interval and subsequently determines whether the N percentage has risen beyond, remained within or fallen below the confidence interval. If both the TLC count and the N percentage have risen beyond the confidence interval, SR5 initiates SR3 and terminates. If TLC has risen beyond the confidence interval but the N percentage has not risen, SR5 enters a monitoring routine to check whether TLC becomes greater 200. If yes, SR5 terminates and initiates SR3. If no, SR5 terminates and initiates SR2. If TLC has remained within or fallen below the confidence interval but the N percentage has risen beyond the confidence interval, SR5 enters a monitoring routine to check whether the N percentage becomes greater 40. If yes, SR5 terminates and initiates SR3. If no, SR5 terminates and initiates SR2.
[0077] In a second scenario, where the baseline mean TLC was between 150 and 400 (subclinical), SR5 first determines whether the TLC of the new sample is below 800.
[0078] If not, SR5 initiates SR4, produces a signal to discard the milk and treat the cow and terminates. If yes, SR5 next determines whether the N percentage has increased. If yes, SR5 initiates SR3 and terminates. If no, SR5 terminates and initiates SR2.
[0079] In a third scenario, where the baseline mean TLC was between 400 and 600 (chronic 1), SR5 first determines whether the TLC of the new sample has risen beyond the confidence interval. If so, SR5 next evaluates whether the TLC of the new sample has remained below 800. If not, SR5 initiates SR4, produces a signal to discard the milk and treat the cow and terminates. If yes, SR5 next determines whether the N percentage has increased. If yes, SR5 initiates SR3 and terminates. If no, SR5 terminates and initiates SR2.
[0080] To summarize the exemplary procedure starting from SR1, the daily counts are compared to the previous counts. If any leukocyte value increases or decreases by 50% in a 24 hour period it is considered unstable and monitoring continues unless the TLC exceeds 600 in which case the next 5 daily test TLC will either rise or fall calling for implementation of SR3 (acute infection) or SR2 (recovery)respectively. If however, the TLC never rises to 600 monitoring continues until the values become stable. After 7 test days in the stable condition the means and 95% confidence intervals for each value (L, N, M and TL count) is determined, this is referred to as the baseline for the quarter. Once the baseline is established the quarter counts are monitored daily until a significant deviation from baseline is detected (SR5).
[0081] If, while establishing baseline, the quarter TLC rises above 600 but less than 1,000 the next test will determine if SR2 (recovery) or SR3 (acute) is employed as a subroutine. Should the quarter rise to >1,000 or an N count greater than 600, it is immediately subjected to SR4 (leukocyte kinetics) monitoring.
[0082] This is because once the TLC exceeds 600 one of several phenomena occurs. First there may be an infection in another quarter which is causing an elevation in the neutrophil count of the monitored quarter. Second this quarter may be beginning an infection and must be watch carefully to document whether or not the infection remains subclinical, develops into a chronic disease, becomes worse, or goes into recovery. The object here is to prevent clinical mastitis which usually occurs when the TLC exceeds 2000. The program will be queried here to see if any other quarter has been diagnosed as mastitic in the previous 7 days, if mastitis is present, this quarter should recover after the infected quarter is treated and followed using SR2. If, however, there is no other indication for the elevated neutrophil count or the neutrophil count in the observed quarter does not decrease after treatment of the adjacent infected quarter, the quarter should be presumed infected and monitored using SR3.
[0083] The SR3 subroutine is used for unstable counts and high TLC in quarters without a baseline or when a quarter with a stable baseline shows a significant deviation from baseline. It is based on the concept that quarters may undergo transient infections in and out of thresholds considered subclinical (150-400) or they may progress into a chronic infection (400-600) before becoming acutely mastitic and clinical. SR3 follows the daily increases (or decreases) in leukocytes to determine if a higher category of infection is imminent. Changes in TLC and especially N count which cross over more than a single threshold in 24 hours have a high rate-of-change consistent with acute infection which must be treated. This high rate of change is rarely seen in chronic or subclinical infection where continued monitoring is advised. Many early infections undergo self cure after a few days and do not necessitate treatment (which removes the cow from the milking herd until antibiotic residues are cleared from the milk resulting in a loss of hundreds of Kgs of milk). As a result sudden very high increases of either TLC or N count would prompt SR4 kinetics or immediate treatment while moderate changes in TLC and N are best monitored to see if they result in self cures (recovery).
[0084] Once the TLC or N exceeds 1,000 kinetics or immediate treatment is advised depending on exactly what the count is and whether or not the animal is showing systemic signs of disease i.e., fever, loss of appetite, loss of rumen contractions. Presence of systemic signs call for immediate treatment or culling of the animal from the herd. When possible it is best to capture several 24 hour MDLC in order to establish the period of moderate increasing cell count (subclinical period), the period of rapidly increasing cell count, the peak cell count, the period of peak plateau, and the final baseline count. The presence or absence of a subclinical period before a period of rapidly increasing cell count is indicative of gram positive infections; absence of this subclinical period is indicative of gram negative infections (all of which are generally treated the same). The peak height of the rapid increasing cell count is indicative of the type of gram negative or gram positive infection. The length between the beginning of the subclinical period and the period of rapid increasing cell count is indicative of different gram positive infections as is the length of the peak plateau and the final post recovery baseline.
[0085] Another important factor used to diagnose species-specific mastitis is the timing of entry into the milk of the various leukocyte populations. E. coli infection is heralded by the rapid recruitment of N into milk in 2 to 4 hours, followed by the recruitment of L and M within 6 hours of infection. This rapid recruitment of all three leukocyte populations is also typical of other gram negative bacteria (which are all treated with the same antibiotics). Gram positive bacteria have more species-specific changes in leukocyte recruitment with delays seen in the recruitment of macrophages and lymphocytes, sometimes by days after infection.
[0086] Thus SR3 is used while TLC is changing between 150 and 800. During this time the count may go back down to baseline or it may increase above 800 in which case you have at least 24 hours of kinetics in SR4 in which to base a species-specific diagnosis.
[0087] If at any time the TLC or N count begins to decrease they should be monitored using SR2 for recovery. This subroutine will indicate when it is indicated to establish a new baseline.
[0088] At any time usually >80% of all quarters of cows in a herd have leukocyte values at baseline. The use of SR2-4 should be an anomaly.
KEY TO FIGURES
[0089] TLCTotal Leukocyte Count
[0090] NCNeutrophil Count
[0091] MCMacrophage Count
[0092] LCLymphocyte Count
[0093] % NPercent Neutrophils
[0094] % MPercent Macrophages
[0095] % LPercent Lymphocytes
[0096] Increasing
[0097] Decreasing
[0098] -No Change in Number or Percentage
[0099] RxTreatment
[0100] CullRemove Animal from Herd
[0101] SCSubclinical Infection
[0102] Gm+Bacteria is Gram Stain Positive
[0103] GmBacteria is Gram Stain Positive